Leveraging the EU AI Act to your advantage

Using the EU AI Act to your advantage

from

Guidelines for the risk assessment of AI use cases
Recommendations for the successful realization and implementation of the AI Act, as well as for the strategic orientation in the company
Exemplary use cases with concrete risk analysis

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

How do you make 30 years of data accessible?

In conversation with Jonas Münch, who developed a RAG chatbot at Bayer that combines 30 years of internal data and clinical results in one place.

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Article

From bottleneck to breakthrough: Why AI is crucial for progress in healthcare and pharma

Rising costs, a shortage of specialists and a flood of data are pushing the healthcare system and the pharmaceutical industry to their limits. Why artificial intelligence is now the key to taking care, research and development to a new level.

Article

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Article

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Leveraging the EU AI Act to your advantage

Guidelines for the risk assessment of AI use cases
Recommendations for the successful realization and implementation of the AI Act, as well as for the strategic orientation in the company
Exemplary use cases with concrete risk analysis